IC
TARS icon

IEQ Capital’s Tarsus Pharmaceuticals TARS Stock Holding History

IEQ Capital’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-7,627
Closed -$453K – 2007
2025
Q3 		$453K Sell
7,627
-13
-0.2% -$640 ﹤0.01% 1343
2025
Q2 		$309K Buy
+7,640
New +$344K ﹤0.01% 1377
2024
Q4 		– Sell
-12,640
Closed -$416K – 1434
2024
Q3 		$416K Sell
12,640
-114
-0.9% -$3.2K 0.01% 814
2024
Q2 		$347K Sell
12,754
-5,000
-28% -$168K ﹤0.01% 758
2024
Q1 		$645K Hold
17,754
– – 0.01% 559
2023
Q4 		$360K Buy
17,754
+6,895
+63% +$115K 0.01% 678
2023
Q3 		$193K Buy
+10,859
New +$192K ﹤0.01% 841

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

IEQ Capital's TARS Position: Q4 2025 in Review

IEQ Capital sold out of Tarsus Pharmaceuticals (TARS) in Q4 2025, closing a stake of 7,627 shares — an estimated $453K sold.

IEQ Capital first reported a position in TARS in Q3 2023 and held it in 7 quarters. The position peaked at $645K in Q1 2024. 246 funds tracked by Wall St. Rank hold TARS as of Q4 2025.

  • IEQ Capital reported no remaining Tarsus Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • IEQ Capital sold 7,627 Tarsus Pharmaceuticals shares in Q4 2025, an estimated $453K.
  • IEQ Capital first reported a position in Tarsus Pharmaceuticals in Q3 2023 and held it in 7 quarters.
  • IEQ Capital's Tarsus Pharmaceuticals position peaked at $645K in Q1 2024.
  • 246 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q4 2025.

Based on IEQ Capital's 13F filing for Q4 2025, filed 13 Feb 2026.